The company has purchased more than 15 acres of land in the Ann Arbor Research Park area for the facility, and it expects the project to create 160 jobs over three years.

The new plant will open in late 2023, according to the firm.

Sartorius is expanding its presence by opening a new plant in Ann Arbor, MI, in 2023. Image courtesy of Sartorius.

McMaster, Sartorius partner on improving biomanufacturing
Sartorius Stedim Biotech and McMaster University, which is located in Hamilton, Ontario, Canada, plan to collaborate on an effort to improve advanced...

Sartorius buys viral vector media company Xell for $59M
Sartorius Stedim Biotech has acquired cell culture company Xell, which is headquartered in Bielefeld, Germany.

Sartorius acquires majority stake in CellGenix
Life science company Sartorius has acquired a 51% stake in reagent manufacturer CellGenix through its subsidiary Sartorius Stedim Biotech.

Sartorius expands biopharma manufacturing in Slovenia
Sartorius plans to expand production facilities for purification products for vaccines and therapies at its facility in Ajdovscina, Slovenia.

Sartorius contributes to Penn State cell culture facility
Sartorius Stedim Biotech has donated $1.5 million to Pennsylvania State University (Penn State) for the creation of the Sartorius Cell Culture Facility,...